Task: Answer the multiple-choice question.
Query: Which drug exhibits a -8.804% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) COc1ccc(CCNC(=O)CSc2nnnn2-c2ccccc2)cc1
b.) Cc1cc(C)n(CC(=O)N/N=C/c2cc([N+](=O)[O-])ccc2O)n1
c.) O=C(NCc1ccc(Cl)cc1)Nc1ccc(F)cc1
Answer: a. COc1ccc(CCNC(=O)CSc2nnnn2-c2ccccc2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(CCNC(=O)CSc2nnnn2-c2ccccc2)cc1
COc1ccc(CCNC(=O)CSc2nnnn2-c2ccccc2)cc1
N-[2-(4-methoxyphenyl)ethyl]-2-(4-phenyltetrazol-5-yl)sulfanylacetamide